FDA approved JUVÉDERM VOLBELLA® XC, for use in the lips for lip augmentation and for correction of perioral rhytids, commonly referred to as perioral lines, in adults over the age of 21.

In clinical trials, JUVÉDERM VOLBELLA® XC was found to effectively increase lip fullness and soften the appearance of lines around the mouth in a majority of subjects through one year. At three months, 80.3% of patients had at least a 1-point improvement in lip fullness and 96.1% of patients treated with JUVÉDERM VOLBELLA® XC reported improvement in satisfaction with their lips.